본문 바로가기

분류 전체보기

(819)
Companies in Digestive Disorders Therapeutics Market Due to various factors, the incidence and prevalence of digestive disorders have increased significantly over the past few decades. These disorders exhibit a wide range of symptoms and possess great challenges as they can lead to many life-threatening complications. However, some of the key players such as ImmunoGenX, Takeda, 9 Meters Biopharma, Falk Pharma, Zedira, Cour Pharmaceutical, Precigen..
Diabetes Types and Treatment Options Diabetes over the past few years has emerged as a public health issue for many countries worldwide. As per the CDC, diabetes is the seventh leading cause of death in the United States and is a significant cause for kidney failure, lower-limb amputations, and adult blindness. If it remains undiagnosed and untreated, it increases the chance of getting many other health complications in later life...
Alzheimer’s Disease Therapeutics Market Alzheimer’s disease (AD) is a progressive neurodegenerative disease that affects memory and other important mental function. Alzheimer’s disease is a lead cause of dementia in approximately 5.8 million Americans. At present, Alzheimer’s disease market faces an unmet need for disease-modifying therapy. However, to fulfil the demand for a better treatments option in the market, several key players..
ABSSSI Therapeutics Market As per the DelveInsight, the ABSSSI pipeline appears quite active with several emerging candidates in Phase III and Phase II stages of development, with many more in the early stages of development. At present, the key pharmaceutical companies including Innovation Pharmaceuticals, MotifBio, Basilea Pharmaceutica, Debiopharm, Destiny Pharma, KBP Biosciences, MicuRx Pharmaceuticals, and several ot..
Sleep Disorders Causes, Diagnosis, and Treatments Over the past few years, sleep disorders have emerged as a key public health issue affecting the mental and physical well being of the person. More than 80 types of sleeping disorders are identified, and among them, Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, Circadian Rhythm Disorders are the most common sleeping disorders that affect a significant proportion of the population wor..
Ewing Sarcoma Emerging Therapies Ewing sarcoma is a type of bone or soft tissue cancer that primarily affects children and young adults. As per the NORD, “the annual Ewing sarcoma incidence is reported to be 3 children per 1,000,000. Around 200–250 children and youngsters in the US are diagnosed with Ewing’s sarcoma each year”. To provide effective therapeutics option, at present some of the key companies at the global level in..
Cancer Anorexia Therapy Market Anorexia is the most common symptom that cancer patients experience. The prevalence of Anorexia in cancer patients can be observed from the fact that it falls amongst the top three common symptoms in cancer patients. The incidence of anorexia by cancer types (in advanced cancers, namely, colorectal cancer, lung cancer, pancreatic cancer, head and neck cancer, gastroesophageal cancer, and liver c..
Alpha-1 Antitrypsin Deficiency Therapy Market Alpha1 antitrypsin deficiency (AATD) is a hereditary disorder, associated with the lack or deficiency of alpha 1 antitrypsin in the blood, a protein that helps in the proper and healthy functioning of the lungs. The prevalence of Alpha 1 antitrypsin deficiency varies according to the origin of the population. As per DelveInsight, in 2017, the total number of AATD prevalent cases in the 6 MM (the..